These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19397412)

  • 1. Opportunities and challenges of developing thermostable vaccines.
    Chen D; Kristensen D
    Expert Rev Vaccines; 2009 May; 8(5):547-57. PubMed ID: 19397412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions.
    Nelson CM; Wibisono H; Purwanto H; Mansyur I; Moniaga V; Widjaya A
    Bull World Health Organ; 2004 Feb; 82(2):99-105. PubMed ID: 15042231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to heat and freezing in the vaccine cold chain in Thailand.
    Techathawat S; Varinsathien P; Rasdjarmrearnsook A; Tharmaphornpilas P
    Vaccine; 2007 Jan; 25(7):1328-33. PubMed ID: 17157419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
    Kristensen DD; Lorenson T; Bartholomew K; Villadiego S
    Vaccine; 2016 Feb; 34(7):899-904. PubMed ID: 26778422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants.
    Braun LJ; Tyagi A; Perkins S; Carpenter J; Sylvester D; Guy M; Kristensen D; Chen D
    Vaccine; 2009 Jan; 27(1):72-9. PubMed ID: 18973782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the effectiveness of cold chain management for childhood vaccines.
    Turner N; Laws A; Roberts L
    J Prim Health Care; 2011 Dec; 3(4):278-82. PubMed ID: 22132380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries.
    Wirkas T; Toikilik S; Miller N; Morgan C; Clements CJ
    Vaccine; 2007 Jan; 25(4):691-7. PubMed ID: 16968657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine stabilization: research, commercialization, and potential impact.
    Kristensen D; Chen D; Cummings R
    Vaccine; 2011 Sep; 29(41):7122-4. PubMed ID: 21651941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The key role of vaccine vial monitors in routine and mass immunisation.
    Martin JP; Lloyd J
    J Indian Med Assoc; 2005 Dec; 103(12):686-7. PubMed ID: 16821666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a thermostable hepatitis B vaccine formulation.
    Braun LJ; Jezek J; Peterson S; Tyagi A; Perkins S; Sylvester D; Guy M; Lal M; Priddy S; Plzak H; Kristensen D; Chen D
    Vaccine; 2009 Jul; 27(34):4609-14. PubMed ID: 19523912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tools and approaches to ensure quality of vaccines throughout the cold chain.
    Kartoglu U; Milstien J
    Expert Rev Vaccines; 2014 Jul; 13(7):843-54. PubMed ID: 24865112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for maintaining and managing the vaccine cold chain.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(42):1023-5. PubMed ID: 14574279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in vaccine stability monitoring technology.
    Zweig SE
    Vaccine; 2006 Aug; 24(33-34):5977-85. PubMed ID: 16759766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the stability of live oral attenuated bacterial vaccines.
    Cryz SJ; Pasteris O; Varallyay SJ; Fürer E
    Dev Biol Stand; 1996; 87():277-81. PubMed ID: 8854028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring temperatures in the vaccine cold chain in Bolivia.
    Nelson C; Froes P; Dyck AM; Chavarría J; Boda E; Coca A; Crespo G; Lima H
    Vaccine; 2007 Jan; 25(3):433-7. PubMed ID: 17000036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Computerized temperature monitoring of the vaccine cold chain in a tropical climate, Chad].
    Schlumberger M; Mireux F; Tchang SG; Mboutbogol D; Cheikh DO; Hissein AA; Youssouf BO; Brahimi MM; Gamatié Y
    Med Trop (Mars); 2011 Jun; 71(3):264-6. PubMed ID: 21870554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine cold chain: part 1. proper handling and storage of vaccine.
    Rogers B; Dennison K; Adepoju N; Dowd S; Uedoi K
    AAOHN J; 2010 Aug; 58(8):337-4; quiz 345-6. PubMed ID: 20704122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine transport and storage: environmental challenges.
    Zaffran M
    Dev Biol Stand; 1996; 87():9-17. PubMed ID: 8853997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of vaccine stability.
    Volkin DB; Burke CJ; Sanyal G; Middaugh CR
    Dev Biol Stand; 1996; 87():135-42. PubMed ID: 8854010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay.
    Schlehuber LD; McFadyen IJ; Shu Y; Carignan J; Duprex WP; Forsyth WR; Ho JH; Kitsos CM; Lee GY; Levinson DA; Lucier SC; Moore CB; Nguyen NT; Ramos J; Weinstock BA; Zhang J; Monagle JA; Gardner CR; Alvarez JC
    Vaccine; 2011 Jul; 29(31):5031-9. PubMed ID: 21616113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.